Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Inavolisib, Ribociclib, and Fulvestrant in Advanced Breast Cancer
NCT07618390Phase 2Not yet recruiting
- Sponsor
- Sun Yat-sen Memorial Hospital
- Start
- Jun 2026
- Primary completion
- Dec 2028
01
Overview
A Phase 2 trial of inavolisib in breast cancer, sponsored by Sun Yat-sen Memorial Hospital. Planned start Jun 2026; status: not yet recruiting.
02
Drugs
inavolisib
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT07618390.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07618390.